IP Library Granted Patent US 10,046,172
Granted Patent B2
US 10,046,172 · App. 14/774,688 · Granted Aug 14, 2018

Controller and flexible coils for administering therapy, such as for cancer therapy

Inventors: John T. Butters (Langley, WA); Bennett M. Butters (Lacey, WA); Mike Ammerman (San Clemente, CA); Scott Conway (Yorba Linda, CA); Robert Fish (Rancho Cucamonga, CA); Larry Hood (Irvine, CA); Jared Nathanson (Mission Viejo, CA); Kevin Oberkramer (Placentia, CA); Kathryn Kukulka (Laguna Beach, CA); Andrew March (Lake Forest, CA)
Assignee: Nativis, Inc.
A61N2/02A61N2/002A61N2/004G01N37/005A61B2562/0223A61M2037/0007A61M2250/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,046,172
App. No.
14/774,688
Granted
Aug 14, 2018
Kind
B2
Abstract

Disclosed herein are systems and methods for providing a portable magnetic field therapy system for treatment of diseases and adverse health conditions, such as cancer.

Claims (28)

1. A method for providing a magnetic therapeutic signal to a mammalian patient, wherein the mammalian patient is capable of being responsive to the magnetic therapeutic signal in a desired manner, the method comprising:

providing a portable system having an electromagnetic transducer portion connected to a signal generator portion,

wherein the signal generator portion includes a stored therapeutic signal obtained from a sample of a chemical or biochemical agent,

wherein the stored therapeutic signal is within a frequency range of about 1 Hz and 22 kHz, and

wherein the stored therapeutic signal is secured or encrypted within the signal generator portion;

securing the signal generator to the patient and the electromagnetic transducer portion to an area of the patient to be treated;

checking for an appropriate connection between the electromagnetic transducer portion and the signal generator portion;

unsecuring or decrypting the stored therapeutic signal;

starting a timer;

generating the magnetic therapeutic signal directed to the area of the patient to be treated, wherein the magnetic therapeutic signal is derived from the stored therapeutic signal; and

when the timer reaches a predetermined value, disabling the signal generator portion of the portable system to prohibit reuse of the stored therapeutic signal.

2. The method of claim 1 wherein the stored therapeutic signal is encrypted within the signal generator portion, and wherein unsecuring the stored therapeutic signal includes decrypting the stored therapeutic signal.

3. The method of claim 1 wherein disabling the signal generator portion includes erasing the stored therapeutic signal.

4. The method of claim 1 wherein checking for an appropriate connection includes determining a type of the electromagnetic transducer portion of the portable system, and wherein the method includes adjusting an amplification of the magnetic therapeutic signal based on the determined type.

5. The method of claim 1 wherein checking for an appropriate connection includes reading identification information from the electromagnetic transducer portion.

6. The method of claim 1 wherein checking for an appropriate connection includes periodically confirming that the electromagnetic transducer portion continues to maintain a physical resistance value within tolerance.

7. The method of claim 1 wherein the stored therapeutic signal is obtained from the sample of the chemical or biochemical agent by:

providing the sample of the chemical or biochemical agent within an electromagnetic shielding structure and proximate to at least one superconducting quantum interference device (SQUID) or magnetometer;

placing the sample of the chemical or biochemical agent in a container having both magnetic and electromagnetic shielding,

wherein the sample of the chemical or biochemical agent acts as a signal source for the stored therapeutic signal;

injecting noise into the sample in the absence of another signal from another signal source at a noise amplitude sufficient to generate stochastic resonance,

wherein the noise has a substantially uniform amplitude over multiple frequencies;

detecting, via the superconducting quantum interference device (SQUID) or magnetometer, output radiation from the sample of the chemical or biochemical agent and recording an electromagnetic time-domain signal composed of sample source radiation superimposed on the injected noise in the absence of the another signal; and

repeating the injecting and detecting at each of multiple noise levels within a selected noise-level range until source radiation from the sample of the chemical or biochemical agent is distinguishable over the injected noise.

8. The method of claim 1 wherein checking for an appropriate connection includes providing a user-perceivable alarm when the connection between the electromagnetic transducer portion and the signal generator portion is not detected or is detected outside of a prescribed tolerance.

9. The method of claim 1 , further comprising periodically checking, directly or indirectly, whether an inductance of the electromagnetic transducer portion is within a prescribed tolerance.

10. The method of claim 1 , further comprising periodically checking, directly or indirectly, whether an inductance of the electromagnetic transducer portion is within a prescribed tolerance so as to check proximity of the electromagnetic transducer portion to the patient.

11. The method of claim 1 , further comprising recording a data log capable of being displayed to a user, wherein the data log includes data representing: a status of the timer, any interruptions of the timer, status of the connection between the electromagnetic transducer portion and the signal generator portion, and any error codes.

Assignments (2)
SECURITY INTEREST Recorded Sep 16, 2025
From: EMULATE THERAPEUTICS, INC.
To: STREETERVILLE CAPITAL, LLC
Reel/Frame 072271/0459 →
CHANGE OF NAME Recorded Aug 8, 2024
From: NATIVIS, INC.
To: EMULATE THERAPEUTICS, INC.
Reel/Frame 068521/0090 →
Continuity (2)
Provisional Application 61792547 · Mar 15, 2013
Related Publication 20160030761A1 · Feb 4, 2016
Cited By (2)
US 12,269,484 US 12,622,748